Literature DB >> 9415063

Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.

A Jörns1, R Munday, M Tiedge, S Lenzen.   

Abstract

The in vitro toxicity of the diabetogenic agent alloxan as documented by the induction of beta cell necrosis was studied in isolated ob/ob mouse pancreatic islets. The effect of alloxan has been compared with that of a number of N-alkyl alloxan derivatives and with that of the structurally related compound, ninhydrin. Alloxan and its derivatives were selectively toxic to pancreatic beta cells, with other endocrine cells and exocrine parenchymal cells being well preserved, even at high concentration. In contrast, ninhydrin was selectively toxic to pancreatic beta cells only at comparatively low concentration, destroying all islet cell types at high concentrations. The ultrastructural changes induced by all the test compounds in pancreatic beta cells in vitro were very similar to those observed during the development of alloxan diabetes in vivo. The relative toxicity of the various compounds to pancreatic beta cells in vitro was not, however, related to their ability to cause diabetes in vivo. Indeed, the non-diabetogenic substances ninhydrin, N-butylalloxan and N-isobutylalloxan were very much more toxic to isolated islets than the diabetogenic compounds alloxan and N-methylalloxan. These results suggest that the differences in diabetogenicity among alloxan derivatives are not due to intrinsic differences in the susceptibility of the pancreatic beta cells to their toxicity, but may reflect differences in distribution or metabolism. High concentrations of glucose protected islets against the harmful effects of alloxan and its derivatives, but not those of ninhydrin. Low levels of glucose, and non-carbohydrate nutrients, afforded little protection, indicating that the effect of glucose is not due to the production of reducing equivalents within the cell, 3-O-Methylglucose, which protects against alloan diabetes in vivo, did not protect against alloxan toxicity in vitro. Since 3-O-methylglucose is known to prevent uptake of alloxan by pancreatic beta cells, it appears that uptake of alloxan by the cell is not a prerequisite for the induction of beta cell necrosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415063     DOI: 10.1677/joe.0.1550283

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Differential susceptibility of chick and mouse islets to streptozotocin and its co-relation with islet antioxidant status.

Authors:  Manisha A Modak; Savita P Datar; Ramesh R Bhonde; Saroj S Ghaskadbi
Journal:  J Comp Physiol B       Date:  2007-01-05       Impact factor: 2.200

2.  Pseudoislet formation enhances gene expression, insulin secretion and cytoprotective mechanisms of clonal human insulin-secreting 1.1B4 cells.

Authors:  Alastair D Green; Srividya Vasu; Neville H McClenaghan; Peter R Flatt
Journal:  Pflugers Arch       Date:  2015-01-06       Impact factor: 3.657

3.  A novel in vitro approach to test the effectiveness of fish oil in ameliorating type 1 diabetes.

Authors:  Moitreyi Das; Arnab Banerjee; Ramaballav Roy
Journal:  Mol Cell Biochem       Date:  2022-05-11       Impact factor: 3.396

Review 4.  The mechanisms of alloxan- and streptozotocin-induced diabetes.

Authors:  S Lenzen
Journal:  Diabetologia       Date:  2007-12-18       Impact factor: 10.122

5.  Antidiabetic activity of medium-polar extract from the leaves of Stevia rebaudiana Bert. (Bertoni) on alloxan-induced diabetic rats.

Authors:  Himanshu Misra; Manish Soni; Narendra Silawat; Darshana Mehta; B K Mehta; D C Jain
Journal:  J Pharm Bioallied Sci       Date:  2011-04

6.  Assessment of the antidiabetic potential of Cassia grandis using an in vivo model.

Authors:  Sandesh R Lodha; Shrikant V Joshi; Bhavin A Vyas; Mohini C Upadhye; Megha S Kirve; Shweta S Salunke; Sheetal K Kadu; Manasi V Rogye
Journal:  J Adv Pharm Technol Res       Date:  2010-07

7.  Antihyperglycemic and hypolipidemic activities of aqueous extract of Carica papaya Linn. leaves in alloxan-induced diabetic rats.

Authors:  Yasmeen Maniyar; Prabhu Bhixavatimath
Journal:  J Ayurveda Integr Med       Date:  2012-04

8.  Therapeutic potency of saponin rich aqueous extract of Scoparia dulcis L. in alloxan induced diabetes in rats.

Authors:  P Saravana Perumal; P V Anaswara; A Muthuraman; S Krishan
Journal:  Ayu       Date:  2014-04

9.  Hypoglycemic and anti-lipemic effects of the aqueous extract from Cissus sicyoides.

Authors:  Glauce S B Viana; Ana Carolina C Medeiros; Ana Michelle R Lacerda; L Kalyne A M Leal; Tiago G Vale; F José De Abreu Matos
Journal:  BMC Pharmacol       Date:  2004-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.